Counseling patients with type 2 diabetes and insulin resistance in the outpatient setting.
Insulin resistance is a major health concern. Besides being a leading risk factor for type 2 diabetes, it is also associated with hypertension, dyslipidemia, obesity, and cardiovascular disease. Making lifestyle changes can reduce insulin resistance and help prevent the onset of diabetes. For those with type 2 diabetes, treatment with insulin-sensitizing drugs, such as the TZDs and biguanides, can improve glycemic control and prevent some of the adverse consequences of the disease. Adherence to both lifestyle and medication regimens is very important and should be actively supported by all members of the healthcare team. Diabetes educators, including pharmacists, can increase awareness of the underlying pathophysiology and clinical implications of insulin resistance. Diabetes educators also play a vital role in counseling patients with type 2 diabetes on strategies that reduce their risk of hyperglycemic complications and in providing support, education, and guidance. By understanding the disease and its management, diabetes educators can contribute to improved outcomes and help to reduce the impact of this worldwide epidemic.
Campbell
R Keith
RK
The College of Pharmacy, Washington State University, Pullman, Washington (Mr Campbell)
White
John
J
The College of Pharmacy, Washington State University, Spokane, Washington (Dr White)
D000375:Aging / Q000378:metabolism; D000553:Ambulatory Care / Q000379:methods*; D003376:Counseling / Q000379:methods*; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism* / Q000517:prevention & control*; D018450:Disease Progression; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007333:Insulin Resistance; D008019:Life Style; D009765:Obesity / Q000150:complications; D010353:Patient Education as Topic / Q000379:methods*; D010595:Pharmacists; D024382:Professional Role; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D007004:Hypoglycemic Agents